Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Adalimumab/etanercept/infliximab

Keratoderma blenorrhagicum: 3 case reports

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Carter JD, Gerard HC, Hudson AP.Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum. Annals of the Rheumatic Diseases 67: 1181-1183, No. 8, Aug 2008 - USA

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Adalimumab/etanercept/infliximab. React. Wkly. 1212, 5 (2008). https://doi.org/10.2165/00128415-200812120-00015

    Download citation

    Keywords

    • Rheumatoid Arthritis
    • Psoriasis
    • Peripheral Blood Mononuclear Cell
    • Infliximab
    • Skin Lesion